AANS Neurosurgeon | Volume 28, Number 2, 2019

Advertisement

Study Reports Possible Novel Method for Stopping Untreatable Pediatric Brain Cancer

Print Friendly, PDF & Email

Effective Treatment Options Lacking for Leading Killer of Kids with Cancer

 

Researchers used an experimental molecular therapy in preclinical laboratory tests to effectively treat several types of deadly pediatric brain cancer and now propose advancing the treatment to clinical testing in children.

Scientists at the Cincinnati Children’s Cancer and Blood Diseases Institute report testing the small molecule 6-thio-2’deoxyguanosine (6-thio-dG) in brain cancer stem cells derived from tumor cells donated by patients. Researchers also tested the treatment in humanized mouse models of pediatric brain cancer.

The cancers include intrinsic pontine glioma (DIPG), high-grade glioma (HGG) and high-risk medulloblastoma (MB).

Click here to read more.

Calendar/Courses

NeuroSafe 2019 Symposium
Aug. 8-9, 2019; Minneapolis

SNSA Congress 2019
Aug. 8-11, 2019; Cape Town, South Africa

2019 Managing Coding and Reimbursement Challenges
Aug. 22-24, 2019; Rosemont, Ill.

Comments are closed.